Synthesis and Β-Lactamase Inhibition Activity of Diazabicyclooctane Derivatives in Combination with Imipenem

L. He,H. Yang,J. Sun,L. Zhai,J. Ji,X. Ma,D. Tang,Y. Mu,L. Wang,Z. Iqbal,Z. Yang
DOI: https://doi.org/10.1134/s1070363222120428
2022-01-01
Russian Journal of General Chemistry
Abstract:β-Lactamase inhibition is an integral part of combination therapy to tackle antibiotic resistance. So far clavulanic acid is the only β-lactamase inhibitor that exhibits oral bioavailability. We synthesized new diazabicyclooctane derivatives by replacing the SO 3 H with CHXCOOR moiety. The antibacterial activity of these compounds, in combination with imipenem, was determined against ten bacterial strains. All compounds showed variable profile of β-lactamase inhibition, however, most of the compounds were potent against K. pneumoniae 700603 with two- to six-fold minimization of MIC value of imipenem.
What problem does this paper attempt to address?